SAN FRANCISCO - Medical Devices Today has put together an exclusive roundup of the 10 early-stage cardio vascular and peripheral vascular medical technology companies that presented at the "Investment In Innovation (In3) Medical Device Summit" on June 17-19, 2008. (Part 1 of 3)
The Summit was presented by Medtech Insight/Windhover Information and FDC Reports.
The program featured 44 early- to late-stage medical technology company presentations focused into three concurrent market Tracks. For the next three issues, Medical Devices Today will feature a different track beginning this week with Track One.
1) Cardio and Peripheral Vascular
2) Orthopedics and Spine, and
3) Other High-Growth Technologies
TRACK 1 of 3 - CARDIO VASCULAR & PERIPHERAL VASCULAR:
To request more information on these companies, please click on the highlighted links or contact Heej Ko at Tel: +1 (203) 838-4401 x 133.
1) Arterial Remodeling Technologies (ART)
Noisy le Roi, France
ART has developed Biodegradable peripheral and coronary polymer stents that promote the natural remodelling of the injured artery after angioplasty.
2) CardiAQ Valve Technologies
(First-Time Presenter)
Winchester, MA
CVT's platform technology will make aortic valve replacement faster, safer, and less-invasive. without compromising performance
3) ES Vascular Ltd.
Haifa, Israel
First ever endovascular staplers approved in the EU for AAA; under further development for cardio, minimally-invasive and peripheral vascular indications.
4) Genesis Medical Interventional, Inc.
Redwood City, CA
Proximal Occlusion Funnel CatheterT for Embolectomy and Thrombectomy & Scoring Balloon with Drug Delivery Capability.
5) Neochord, Inc.
(First-Time Presenter)
Wayzata, MN
NeoChord is commercializing a Mayo Clinic invention that enables minimally invasive implantation of artificial chordae tendinea. Artificial "chords" are frequently used by cardiac surgeons doing mitral valve repair.
6) PreMD Inc.
Toronto, Canada
PreMD develops non-invasive tests for the risk assessment of cardiovascular disease and the detection of early-stage colorectal, lung and breast cancer.
7) PROTOMED
Marseille, France
PROTOMED develops sutureless devices designed to accelerate peripheral vascular reconstructions and drive changes in Minimally-Invasive Surgery.
8) Tayside Flow Technologies Limited
(First-Time Presenter)
Dundee, Scotland
TFT's proprietary technology reproduces the naturally occuring form of blood flow - Spiral Laminar Flow (SLF). Current products and technologies do not produce SLF, thereby contributing to neo-intimal hyperplasia and, for example, low patency of bypass grafts; therefore TFT's technology represents a potential major improvement in clinical outcomes.
9) Thornhill Research Inc.
(First-Time Presenter)
Toronto, Canada Diagnostic products for neuroimaging and cardiology markets including civilian, military and emergency medicine.
10) Tissue Genetics
Aurora, CO
A predictive medicine company with novel technology for diagnosing breast and ovarian cancer and determining responsiveness to new therapeutics.
To request more information on these companies, please click on the highlighted links or contact Heej Ko at Tel: +1 (203) 838-4401 x 133. Find out how you can participate in an upcoming In3 event.
